Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance)

One of the possible long-term consequences of antipsychotic-induced hyperprolactinemia is the development of pituitary tumors – prolactinomas. So far, two pharmacovigilance studies of spontaneous adverse event report databases have suggested an increased risk, whereas a longitudinal study carried ou